Xcout Intel
Cytokinetics, Incorporated
Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function.
Subscribe to see Cytokinetics, Incorporated’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Cytokinetics, Incorporated at a glance
Cytokinetics, Incorporated is a biotechnology company headquartered in South San Francisco, United States, founded in 1997. It is publicly listed (CYTK) with a market capitalisation of $8.5B. Xcout tracks 24 named people at Cytokinetics, Incorporated, including Robert I. Blum (Chief Executive Officer, President & Director). Xcout recorded 1 job posting from Cytokinetics, Incorporated in the last 90 days.
Cytokinetics, Incorporated leadership
- Robert I. BlumChief Executive Officer, President & Director
- Sung H. LeeEVP & CFO
- Andrew CallosExecutive Vice President & Chief Commercial Officer
- Jeffrey J. HessekielExecutive Vice President, Chief Legal & Administrative Officer
- James H. SabryCo-Founder & Chairman of Scientific Advisory Board
- James A. SpudichCo-Founder & Member of Scientific Advisory Board
18 more named people on record for Cytokinetics, Incorporated, with roles, board committees and tenure — see the full roster →
Hiring at Cytokinetics, Incorporated
Xcout recorded 1 job posting from Cytokinetics, Incorporated in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see Cytokinetics, Incorporated's hiring signals →
Cytokinetics, Incorporated competitors
A few of Cytokinetics, Incorporated's closest competitors — see the full list of competitors and alternatives →
Circle Pharma, Inc. is a clinical-stage biopharmaceutical company headquartered in South San Francisco, California, harnessing macrocycles for drug development.
Edgewise Therapeutics is a biopharmaceutical company that develops novel therapeutics for individuals facing serious cardiovascular diseases, such as hypertrophic cardiomyopathy and heart failure. The company focuses on muscle science and precision therapies to address unmet medical needs in patients and families.
Braveheart Bio, Inc. engages in the development of therapeutics to treat hypertrophic cardiomyopathy. Its lead product candidate is BHB-1839 which is a small-molecule cardiac myosin inhibitor. The company was founded on May 13,2024 and is headquartered in San Francisco, CA.
Akero Therapeutics is a clinical-stage biopharmaceutical company headquartered in South San Francisco, California. The company is dedicated to developing transformational therapies for metabolic dysfunction-associated steatohepatitis and other metabolic diseases.
NGM Biopharmaceuticals, Inc. is a clinical-stage biotechnology company headquartered in South San Francisco, California, focused on discovering and developing transformative therapeutics.
Encoded Therapeutics is a biotechnology company headquartered in South San Francisco, California, dedicated to developing next-generation genetic medicines designed to address the root causes of genetic diseases.
Get Cytokinetics, Incorporated's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Cytokinetics, Incorporated in Xcout Intel
- 24 named people with titles, LinkedIn and board committees
- Weekly hiring history and the mix of roles behind it
- 1 corporate event with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access